Status:

COMPLETED

Reduction Ratio and Clearance During Hemodialysis With MCO-filter Compared to HDF With Standard High-flux Filter

Lead Sponsor:

Region Skane

Collaborating Sponsors:

Lund University

Conditions:

Chronic Kidney Failure

Uremia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The Medium Cut-Off dialysis (MCO) membrane has been developed to improve middle molecule removal compared to standard high-flux dialysis filters. The major aim of this study is to compare the reducti...

Eligibility Criteria

Inclusion

  • Ongoing HDF treatment
  • CRP \<30
  • No Acute Myocardial Infarction within 3 months.

Exclusion

  • Not able to understand the study information.

Key Trial Info

Start Date :

May 21 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 16 2019

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT03437538

Start Date

May 21 2018

End Date

April 16 2019

Last Update

November 13 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Skane University Hospital

Malmo, Sweden